A randomized, double-blind, placebo-controlled study to evaluate botulinum toxin type A in essential hand tremor

Movement Disorders

Volumn 11, Issue 3, 1996, Pages 250-256

  Jankovic, J ^a   Schwartz, K ^a   Clemence, W ^a   Aswad, A ^b   Mordaunt, J ^b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b ALLERGAN INC   (United States)

Author keywords

Botulinum toxin type A; Essential hand tremor

Indexed keywords

BOTULINUM TOXIN A; PLACEBO;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DENERVATION; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; ESSENTIAL TREMOR; EXTENSOR MUSCLE; FEMALE; FINGER; FLEXOR MUSCLE; HAND; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; MEASUREMENT; MUSCLE WEAKNESS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; WRIST;

AGED; BOTULINUM TOXIN TYPE A; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; ELECTROMYOGRAPHY; FEMALE; HAND; HUMANS; INJECTIONS, INTRAMUSCULAR; MALE; MIDDLE AGED; MOTOR SKILLS; NEUROLOGIC EXAMINATION; SIGNAL PROCESSING, COMPUTER-ASSISTED; TREATMENT OUTCOME; TREMOR;

EID: 0029873564     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.870110306     Document Type: Article

References (17)

1. Lou JS, Jankovic J. Tremors. In: Appel SH, ed. Current neurology. Vol. 11, Chicago: Mosby Year Book, 1991:199-232.
2. Bain PG, Findley LJ, Thompson PD, et al. A study of hereditary essential tremor. Brain 1994,117:805-824.
3. Findley LJ. Tremors: differential diagnosis and pharmacology. In: Jankovic J, Tolosa E, eds. Parkinson's disease and movement disorders. Baltimore: Williams & Wilkins, 1993: 293-314.
4. Jankovic J, Schwartz K. Botulinum toxin treatment of tremors. Neurology 1991;41:1185-1188.
5. Trosch RM, Pullman SL. Botulinum toxin A injections for the treatment of hand tremors. Mov Disord 1994;9:601-609.
6. Delagi EF, Perotto A, Iazetti J, Morrison D. Anatomic guide for the electromyographer: The limbs. Springfield, IL: Charles C Thomas, 1980.
7. Bergner M, Bobbin R, Carter W, Gilson B. The sickness impact profile: development and final revision of a health status measure. Med Care 1981;19:787-805.
8. Landis RJ, Heyman ER, Koch GC. Average partial association in three-way contingency tables: a review and discussion of alternative test. Int Stat Rev 1978;46:237-254.
9. Pahwa R, Busenbark K, Swanson-Hyland HF, et al. Botulinum toxin treatment of essential head tremor. Neurology 1995;45:822-824.
10. Ludlow CL, Sedory SE, Fujita M, Naunton RF. Treatment of voice tremor with botulinum toxin injection [Abstract]. Neurology 1989;39(suppl 1):353.
11. Jankovic J, Brin MF. Therapeutic uses of botulinum toxin. N Engl J Med 1991;324:1186-1194.
12. Jankovic J, Hallett M, eds. Therapy with botulinum toxin. New York: Marcel Dekker, 1994:1-595.
13. Jankovic J, Schwartz K. The use of botulinum toxin in the treatment of hand dystonias. J Hand Surg [Am] 1993;18: 883-887.
14. Jankovic J. Essential tremor and other movement disorders. In: Findley LJ, Koller W, eds. Handbook of tremor disorders. New York: Marcel Dekker, 1994:245-261.
15. Hallet M. Is dystonia a sensory disorder? Ann Neurol 1995; 38:139-140.
16. Kaji R, Rothwell JC, Katayama M, et al. Tonic vibration reflex and muscle afferent block in writer's cramp. Ann Neurol 1995;38:155-162.
17. Rondot MD, Korn H, Scherrer J. Suppression of an entire tremor by anesthetizing a selective muscular group. Arch Neurol 1968;19:421-429.